| | Clinical characteristics | | |
| | Age (years) | 71 | 60–78 | | Male (n, %) | 83 | 69.7 | | Height (cm) | 163.0 | 155.5–170.0 | | Body weight (kg) | 60.0 | 51.4–70.0 | | BMI (kg/m2) | 22.6 | 20.0–26.0 | | Diabetes mellitus (n, %) | 41 | 34.4 | | SBP (mmHg) | 98 | 83–119 | | DBP (mmHg) | 58 | 46–64 | | HR (/min) | 93 | 80–113 | | Intubation (n, %) | 42 | 35.3 | | SOFA score | 12 | 10–15 | | Diagnosis at the time of starting CRRT | | Sepsis or severe infectious diseases (n, %) | 39 | 32.8 | | Heart failure (n, %) | 34 | 28.6 | | After cardiovascular surgery (n, %) | 25 | 21.0 | | Hepatic failure (n, %) | 2 | 1.7 | | Mainly renal failure (n, %) | 5 | 4.2 | | Tumor lysis syndrome (n, %) | 2 | 1.7 | | Others (n, %) | 12 | 10.1 | | Laboratory data | | Alb (g/dL) | 2.5 | 2.1–3.0 | | Hb (g/dL) | 10.6 | 8.8–12.5 | | CRP (mg/dL) | 9.9 | 4.3–18.8 | | Details of catheter | | | | Triple lumen catheter (n, %) | 87 | 73.1 | | Catheter position | | Femoral vein (n, %) | 95 | 79.8 | | Jugular vein (n, %) | 24 | 20.2 | | Condition of CRRT | | Mode of CRRT | | CVVHDF (n, %) | 100 | 84.0 | | CVVHD (n, %) | 19 | 16.0 | | Type of hemofilter | | | | PMMA (n, %) | 51 | 42.9 | | CTA (n, %) | 54 | 45.4 | | PS (n, %) | 10 | 8.4 | | PES (n, %) | 3 | 2.5 | | Others (n, %) | 1 | 0.8 | | ACT (sec) | 282 | 243–350 | | Clinical outcome | | Decrease in the blood flow rate (n, %) | 52 | 43.7 | | Catheter-related bloodstream infection (n, %) | 20 | 16.8 | | All-cause death during CRRT (n, %) | 55 | 46.2 | | All-cause death during hospitalization (n, %) | 62 | 52.1 | | Physician who inserted hemodialysis catheter | | Nephrologist (n, %) | 66 | 55.5 | | Over 10 years of experience (n, %) | 52 | 43.7 |
|
|
Continuous variables are presented as the median and interquartile range. Categorical variables are presented as number (n) and frequency (%). ACT, activating coagulation time; Alb, albumin; BMI, body mass index; CRP, C-reactive protein; CRRT, continuous renal replacement therapy; CTA, cellulose triacetate; CVVHD, continuous venovenous hemodialysis; CVVHDF, continuous venovenous hemodiafiltration; DBP, diastolic blood pressure; Hb, hemoglobin; HR, heart rate; PES, polyethersulfone; PMMA, polymethylmethacrylate; PS, polysulfone; SBP, systolic blood pressure; SOFA score, sequential organ failure assessment score.
|
